O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors

Clinical trial NCT00003765 · COMPLETED

Trial details

NCT number: NCT00003765
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 1999-05-01
Primary completion: 2006-03-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.